Skip to main content

Table 2 Treatment information of HCC patients with PVTT

From: Efficacy of radiotherapy in combined treatment of hepatocellular carcinoma patients with portal vein tumor thrombus: a real-world study

Case

RT dose

RT dose level

PTV(CC)

Normal liver PTV (CC)

PT RECIST

PVTT RECIST

Operation

PT cancer burden

PVTT cancer burden

1

3 Gy×10f

low

91.4

844.4

SD

SD

transplantation

70%

0%

2

2 Gy×20f

low

1858.2

992

SD

SD

transplantation

10%

0%

3

4.5 Gy×10f

low

495

1066.2

SD

SD

transplantation

70%

60%

4

5 Gy×8f

low

360

1691.9

SD

SD

transplantation

20%

10%

5

2 Gy×23f

low

661.3

971.3

PR

PR

transplantation

90%

0%

6

3 Gy×10f

low

1700

1026.6

PR

SD

right

50%

50%

7

2 Gy×20f

low

955

1433.5

SD

SD

transplantation

60%

0%

8

2 Gy×25f

high

72

905.9

PR

PR

right

70%

0%

9

2 Gy×18f + 2 Gy×7f

high

988.9

1665.4

PR

PR

right

10%

0%

10

2 Gy×20f

low

474.5

953.5

PR

PR

transplantation

0%

0%

11

3 Gy×20f

high

859.2

1133

PR

PR

transplantation

0%

0%

12

3 Gy×20f

high

1026.8

1338

PR

PR

left

20%

0%

13

2 Gy×20f

low

438.1

10.575

PR

PR

right

0%

0%

14

3 Gy×10f

low

157.759

2128.38

SD

SD

transplantation

20%

0%

  1. PT: primary tumor; PVTT: portal vein tumor thrombus; RECIST: response evaluation criteria in solid tumors; RT: radiotherapy;